GILD: Gilead Sciences, Inc. - Summary | Jitta

Gilead Sciences, Inc.

NASDAQ:GILD

Price
$68.93
Loss Chance
43.2%
5.85JITTA SCORE
26.32%Under Jitta Line
Jitta Ranking
14 / 1,041
380 / 4,594
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (52)
Recent Business Performance (67)
Financial Strength (66)
Return to Shareholders (94)
Competitive Advantage (62)
Jitta Signs
Return on EquityConsistently High
Dividend PayoutIncreasing Every Year
Share RepurchaseEvery Year
CapExVery Low
Interest Coverage RatioVery Good
Revenue and EarningRevenue decline from 2017-2020
Recent Business PerformanceEarning decline 20.49% in the last year
SG&A to SalesIncreasing Every Year
Key Stats
Jitta Score
Jitta Line
5.85
26.32%
1.43
197.95%
2.25
348.40%
Biotechnology
6.28
43.68%
4.83
30.68%
5.90
70.35%
COMPANY DESCRIPTION
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of human immunodeficiency virus (HIV) infection; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr; Tizona; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos; Janssen; Japan Tobacco, Inc.; Gadeta; Bristol-Myers Squibb Company; Merck; and Novo Nordisk A/S. The company was founded in 1987 and is headquartered in Foster City, California.